journal
MENU ▼
Read by QxMD icon Read
search

Cardiology and Therapy

journal
https://www.readbyqxmd.com/read/30218410/effects-of-neostigmine-and-sugammadex-for-reversal-of-neuromuscular-blockade-on-qt-dispersion-under-propofol-anesthesia-a-randomized-controlled-trial
#1
Yusuke Yamashita, Toshifumi Takasusuki, Yoshiyuki Kimura, Makoto Komatsuzaki, Shigeki Yamaguchi
INTRODUCTION: Reversal of non-depolarizing neuromuscular blocking agent neostigmine is associated with QT prolongation under general anesthesia. To clarify the effects of neostigmine and sugammadex on hemodynamic status, the QT interval and QT dispersion after reversal of neuromuscular blockade were evaluated with a 12-lead electrocardiogram. To exclude QT prolongation due to sevoflurane, the present study was performed under propofol anesthesia. METHODS: After receiving approval from the ethics committee of Dokkyo Medical University Hospital, 40 patients with American Society of Anesthesiologists physical status I or II were randomly allocated to group N (n = 20) or group S (n = 20)...
September 14, 2018: Cardiology and Therapy
https://www.readbyqxmd.com/read/30191469/risk-of-hospitalization-for-cardiovascular-events-with-%C3%AE-blockers-in-hypertensive-patients-a-retrospective-cohort-study
#2
Jan Basile, Brent Egan, Henry Punzi, Sanjida Ali, Qian Li, Mehul Patel, Joel Neutel
INTRODUCTION: β-Blockers are a heterogenous class of drugs that are no longer recommended for initial antihypertension monotherapy due to unfavorable long-term cardiovascular events observed with non-vasodilatory β-blockers. However, the comparative cardiovascular event risk between the vasodilatory β1 -selective antagonist/β3 agonist nebivolol and non-vasodilatory β1 -blockers, atenolol and metoprolol, is unknown. METHODS: Incident nebivolol, atenolol, or metoprolol monotherapy users with hypertension were identified using US claims data (2007-2014)...
September 6, 2018: Cardiology and Therapy
https://www.readbyqxmd.com/read/30182342/clopidogrel-versus-newer-p2y12-antagonists-for-percutaneous-coronary-intervention-in-patients-with-out-of-hospital-cardiac-arrest-managed-with-therapeutic-hypothermia-a-meta-analysis
#3
Ayman Elbadawi, Islam Y Elgendy, Ahmed H Mohamed, Kirolos Barssoum, Erfan Alotaki, Gbolahan O Ogunbayo, Khaled M Ziada
INTRODUCTION: The impact of therapeutic hypothermia (TH) on outcomes of percutaneous coronary intervention (PCI) and the optimal antiplatelet treatment remains debatable. METHODS: Electronic databases were searched for randomized trials and observational studies to evaluate the available clinical evidence comparing the use of clopidogrel versus newer P2Y12 antagonists in cases of TH after PCI. The primary outcome was in-hospital definite stent thrombosis while the secondary outcomes were in-hospital mortality and major bleeding...
September 4, 2018: Cardiology and Therapy
https://www.readbyqxmd.com/read/30109507/adherent-intrapericardial-teratoma-a-case-report
#4
Neville A G Solomon, Swaminathan Vaidyanathan, Kothai Sugumar, Musthafa Janeel
Intrapericardial teratomas are rare tumours arising from all three germinal layers. They are mostly benign, but can lead to life-threatening complications such as cardiac tamponade in newborns, so surgical excision of the tumour should be done as early as possible once the diagnosis is made. We report a neonate diagnosed with a large intrapericardial teratoma, managed surgically with the help of cardiopulmonary bypass.
August 14, 2018: Cardiology and Therapy
https://www.readbyqxmd.com/read/30109506/trend-and-outcomes-of-direct-transcatheter-aortic-valve-replacement-from-a-single-center-experience
#5
Anthony A Bavry, Seyed Hossein Aalaei-Andabili, Ki E Park, Calvin Y Choi, Eddie W Manning Iii, Wade W Stinson
INTRODUCTION: When transcatheter aortic valve replacement (TAVR) was introduced, pre-implantation balloon aortic valvuloplasty (BAV) was a routine part of the procedure. Smaller device profiles have resulted in selective use of BAV; however, there is a paucity of data about the trend in use of direct TAVR and the safety of this strategy. METHODS: All patients who underwent TAVR at a Veterans Affairs Medical Center from September 2013 to November 2016 were included in this retrospective analysis...
August 14, 2018: Cardiology and Therapy
https://www.readbyqxmd.com/read/30084047/correction-to-a-novel-bridging-strategy-for-patients-undergoing-emergent-non-cardiac-surgery-with-a-recent-coronary-stent
#6
Cierra Bruck, Omar Jafar, Jayne Prats, Deepak Bhatt, Zubair Jafar
In the original publication, the abstract text, informed consent and disclosure text have been published incorrectly.
August 6, 2018: Cardiology and Therapy
https://www.readbyqxmd.com/read/29995228/a-novel-bridging-strategy-for-patients-undergoing-emergent-non-cardiac-surgery-with-a-recent-coronary-stent
#7
Cierra Bruck, Omar Jafar, Jayne Prats, Deepak Bhatt, Zubair Jafar
INTRODUCTION: Not infrequently, patients undergoing dual antiplatelet therapy for a recent cardiac stent develop a need for a non-cardiac surgery. Most of these surgeries can be delayed while the antiplatelet treatment is stopped and normal platelet function returns in order to avoid potential surgical complications and excessive bleeding. However, there are a number of patients who require urgent surgery where the procedure cannot be postponed. To date, no agents have been proven to bridge the patient off dual-antiplatelet therapy...
July 11, 2018: Cardiology and Therapy
https://www.readbyqxmd.com/read/29785539/the-effect-of-spironolactone-on-the-incidence-of-contrast-induced-nephropathy-in-patients-undergoing-cardiac-catheterization-study-design-and-rationale
#8
Alhasan Mujtaba, Mohammed A Taher, Mazin A Hazza, Hassan M Al-Rubaye, Asaad H Kata, Hamid AbdulWahab, AbdulAmeer AbdulBari, Hayder K AlRubay
INTRODUCTION: Patients undergoing coronary catheterization are at high risk of developing contrast-induced nephropathy (CIN) acute kidney injury (AKI). Several approaches have been supposed to limit such an effect but with mixed results or non-practical methods. Spironolactone is supposed to be effective as a nephroprotective agent in animal studies. This study will try to measure the effect of spironolactone on the incidence of CIN-AKI in patients undergoing coronary catheterization (angiography angioplasty)...
June 2018: Cardiology and Therapy
https://www.readbyqxmd.com/read/29779201/clinical-acceptability-of-trimetazidine-modified-release-80-mg-once-daily-versus-trimetazidine-modified-release-35-mg-twice-daily-in-stable-angina-pectoris
#9
Yuri M Pozdnyakov
INTRODUCTION: Trimetazidine (TMZ) is an anti-ischemic metabolic agent that has been shown to be efficacious in angina treatment, both in monotherapy and in combination. A new formulation of TMZ modified-release (MR) 80 mg was developed, which is to be taken once daily (od), instead of twice daily (bid) for the currently available TMZ MR 35 mg, with the aim of simplifying the medication regimen. METHODS: The present study was an international, multicenter, randomized, double-blind, parallel-group phase III study with a 12-week treatment period...
June 2018: Cardiology and Therapy
https://www.readbyqxmd.com/read/29779200/impact-of-antithrombotic-regimen-on-mortality-ischemic-and-bleeding-outcomes-after-transcatheter-aortic-valve-replacement
#10
Anubodh Varshney, Ryan A Watson, Andrew Noll, KyungAh Im, Jeffrey Rossi, Pinak Shah, Robert P Giugliano
INTRODUCTION: Optimal antithrombotic therapy after transcatheter aortic valve replacement (TAVR) remains unclear. We evaluated the association between antithrombotic regimens and outcomes in TAVR patients. METHODS: We retrospectively analyzed consecutive patients who underwent TAVR at a single academic center from April 2009 to March 2014. Antithrombotic regimens were classified as single or dual antiplatelet therapy (AP), single antiplatelet plus anticoagulant (SAC), or triple therapy (TT)...
June 2018: Cardiology and Therapy
https://www.readbyqxmd.com/read/29667131/pulmonary-embolism-following-incomplete-surgical-resection-of-a-right-ventricular-myxoma-a-case-report-and-review-of-the-literature
#11
Yazan Assaf, Maher Nasser, Hani Jneid, David Ott
Right ventricular (RV) myxomas are extremely rare, but may have dreadful clinical sequelae including pulmonary embolism (PE). We present a case of a patient who had an RV myxoma that was attached to the tricuspid valve, and therefore could not be resected completely during surgery, and remnants of the tumor were seen on transthoracic echocardiogram during post-operative follow-up. Five months after surgery, the patient had PE, which could be due to tumor emboli or thromboemboli. Since repeat surgical resection was not feasible, the patient was started on warfarin...
June 2018: Cardiology and Therapy
https://www.readbyqxmd.com/read/29633088/dual-antithrombotic-therapy-with-clopidogrel-and-novel-oral-anticoagulants-in-patients-with-atrial-fibrillation-undergoing-percutaneous-coronary-intervention-a-real-world-study
#12
Julia Kebernik, Martin Borlich, Ralph Tölg, Mohamed El-Mawardy, Mohamed Abdel-Wahab, Gert Richardt
INTRODUCTION: For patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI), proper antithrombotic therapy is equivocal. Current guidelines recommend triple therapy, which carries a high risk of bleeding. Recent large trials suggest that dual therapy (DT) with novel oral anticoagulant (NOAC) plus P2Y12 inhibitor can be an appropriate alternative, but real-world data for this alternative are scarce and the optimal duration of DT has not yet been established...
June 2018: Cardiology and Therapy
https://www.readbyqxmd.com/read/29525891/a-review-of-the-role-of-non-vitamin-k-oral-anticoagulants-in-the-acute-and-long-term-treatment-of-venous-thromboembolism
#13
REVIEW
Andrew Bromley, Anna Plitt
Venous thromboembolism (VTE), which includes both deep vein thrombosis and pulmonary embolism (PE), is a very common disorder with high risk for recurrence and is associated with significant morbidity and mortality. The non-vitamin K oral anticoagulants (NOACs), which include dabigatran, rivaroxaban, apixaban, and edoxaban, have been shown to be noninferior to conventional anticoagulant therapy for the prevention of recurrent VTE and are associated with more favorable bleeding risk. Evidence from the treatment of VTE with traditional therapy (low molecular weight heparin and vitamin K antagonists) implies that extended or indefinite treatment reduces risk of recurrence...
June 2018: Cardiology and Therapy
https://www.readbyqxmd.com/read/29520573/correction-to-exosomes-in-cardiovascular-medicine
#14
Iain M Dykes
This article was originally published under a [CC BY-NC-SA 4.0/CC BY-NC-ND 4.0] license, but has now been made available under a CC BY 4.0 license.
June 2018: Cardiology and Therapy
https://www.readbyqxmd.com/read/29488150/stroke-prevention-with-oral-anticoagulants-summary-of-the-evidence-and-efficacy-measures-as-an-aid-to-treatment-choices
#15
REVIEW
José Francisco Kerr Saraiva
Atrial fibrillation (AF) is an established risk factor for a first or recurrent stroke. Despite proven efficacy in preventing stroke in patients with AF, warfarin is underused, partly due to safety concerns. Recent randomized trials have shown that non-vitamin K antagonist oral anticoagulants (NOACs) such as dabigatran (a direct thrombin inhibitor) and apixaban, edoxaban, and rivaroxaban (factor Xa inhibitors) are not only non-inferior or superior to warfarin but also demonstrate a decreased risk of cerebrovascular bleeding among patients with AF and moderate to high risk of stroke...
June 2018: Cardiology and Therapy
https://www.readbyqxmd.com/read/29417406/a-review-of-interleukin-1-in-heart-disease-where-do-we-stand-today
#16
REVIEW
Yishay Szekely, Yaron Arbel
Cardiovascular diseases are the leading cause of death worldwide. Research in the last two decades has emphasized the inflammatory process as a key component in the pathogenesis of many of them. The Interleukin-1 family is a pivotal element of inflammation and has been well studied as a therapeutic target in various inflammatory states. Recent trials have explored the effect of Interleukin-1 blockade in cardiovascular diseases and initial evidence of the relevance of such treatment in this field of medicine accumulate...
June 2018: Cardiology and Therapy
https://www.readbyqxmd.com/read/29411245/single-coronary-artery-anomaly-a-case-report-and-review-of-literature
#17
Ayman Elbadawi, Basarat Baig, Islam Y Elgendy, Erfan Alotaki, Ahmed H Mohamed, Kirolos Barssoum, David Fries, Muhammad Khan, Rami N Khouzam
INTRODUCTION: Single coronary artery is a rare anomaly, which is usually associated with other cardiac congenital abnormalities. CASE REPORT: A 56-year-old female presented with unstable angina. The patient reported complaints of typical chest pain on exertion few months prior to presentation, which progressed to become at rest. The pain was associated palpitations and dizziness. Past medical history was significant for hypertension and hyperlipidemia. Vital signs were stable...
June 2018: Cardiology and Therapy
https://www.readbyqxmd.com/read/29218644/cardiovascular-complications-of-marijuana-and-related-substances-a-review
#18
REVIEW
Amitoj Singh, Sajeev Saluja, Akshat Kumar, Sahil Agrawal, Munveer Thind, Sudip Nanda, Jamshid Shirani
The recreational use of cannabis has sharply increased in recent years in parallel with its legalization and decriminalization in several countries. Commonly, the traditional cannabis has been replaced by potent synthetic cannabinoids and cannabimimetics in various forms. Despite overwhelming public perception of the safety of these substances, an increasing number of serious cardiovascular adverse events have been reported in temporal relation to recreational cannabis use. These have included sudden cardiac death, vascular (coronary, cerebral and peripheral) events, arrhythmias and stress cardiomyopathy among others...
June 2018: Cardiology and Therapy
https://www.readbyqxmd.com/read/29164408/long-term-clinical-outcome-of-early-generation-versus-new-generation-drug-eluting-stents-in-481-patients-undergoing-rotational-atherectomy-a-retrospective-analysis
#19
Abdelhakim Allali, Erik W Holy, Dmitry S Sulimov, Ralph Toelg, Gert Richardt, Mohamed Abdel-Wahab
INTRODUCTION: New-generation drug-eluting stents (NG-DES) are superior to early generation DES (EG-DES) in the majority of lesion and patient subsets, but comparative data in patients with severely calcified coronary lesions are lacking. This study aims to compare clinical outcomes of EG-DES and NG-DES in patients undergoing rotational atherectomy (RA) in calcified lesions. METHODS: Data of 268 patients (288 lesions) treated with EG-DES and 213 patients (225 lesions) receiving NG-DES after RA were retrospectively analyzed from a single-center registry...
June 2018: Cardiology and Therapy
https://www.readbyqxmd.com/read/29116618/treatment-of-stable-angina-with-a-new-fixed-dose-combination-of-ivabradine-and-metoprolol-effectiveness-and-tolerability-in-routine-clinical-practice
#20
Dimitar Divchev, Georg Stöckl
INTRODUCTION: In this prospective, multicenter, observational cohort study, the effectiveness and tolerability of the first fixed-dose combination (FDC) formulation of the selective heart rate reducing agent ivabradine and the beta-blocker metoprolol was evaluated in stable angina pectoris (AP) patients in a clinical practice setting. METHODS: Stable AP outpatients received a FDC of ivabradine and metoprolol (b.i.d.) for 4 months, in addition to cardiovascular standard therapy...
December 2017: Cardiology and Therapy
journal
journal
48935
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"